This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Assess which is better for you: index funds or active funds, focusing on costs, performance consistency, and your investment horizon.
24,613 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
SoundHound AI has delivered notable revenue gains, even as its stock retreated. This article breaks down what's drivi...
A fresh wave of AI-driven momentum is reshaping Amazon's outlook, and investors are paying close attention. This arti...
The Council of MLS Services appointed Jessica Edgerton as the next CEO, with a start date of July 1, 2026. The move e...
A real-world hotel-charge fraud case highlights how easy it is for card data to be misused. This practical guide show...
This article dives into amerisafe (amsf) 2025 earnings expectations, outlining key drivers, potential pitfalls, and a...
A firsthand look at NAR's leadership transition reveals a new operating tempo and renewed focus on accountability. Th...
A rising iPhone upgrade cycle is quietly lifting a little-known stock. This article breaks down why the move makes it...
A new wave of AI-enabled lending could be headed for auto loans. This article explains why upstart's auto loan push m...
Adobe has fallen sharply in 2026, prompting a rotation debate toward Alphabet as AI momentum and big-cap investments ...
A new Gallup survey ties regular AI use to lower layoff risk in the U.S. job market. The findings challenge the idea...
BrightSpring’s latest earnings call shed light on growth trends, margin discipline, and a cautious yet hopeful outloo...